drugset / Trial / NCT00695565

Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic Neuropathy

NCT00695565

Phase 2 Completed 180 enrolled Arcion Therapeutics Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether ARC-4558 is effective in managing pain associated with painful diabetic neuropathy.

Timeline

Start
2008-05
Primary completion
2009-12
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clonidine Other / unclassified 0.1 % Topical